Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Morphine Antikörper

Der Maus Monoklonal anti-Morphine Antikörper (Klon BDI263) (ABIN263877) detektiert spezifisch Morphine in LF und EIA.
Produktnummer ABIN263877
870,77 €
Zzgl. Versandkosten 20,00 € und MwSt
1 mg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für Morphine Antikörper (ABIN263877)

Target

Morphine

Wirt

  • 30
  • 5
  • 2
  • 1
Maus

Klonalität

  • 30
  • 8
Monoklonal

Konjugat

  • 19
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Morphine Antikörper ist unkonjugiert

Applikation

  • 20
  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Lateral Flow (LF), Enzyme Immunoassay (EIA)

Klon

BDI263
  • Aufreinigung

    Protein A chromatography

    Immunogen

    Morphine-BTG

    Isotyp

    IgG1
  • Applikationshinweise

    Tested in a rapid test (lateral flow) format.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    2.58mg/mL

    Buffer

    0.15 M PBS, pH 7.4 containing 0,09 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
    Shelf life: one year from despatch.

    Haltbarkeit

    12 months
  • Target

    Morphine

    Substanzklasse

    Chemical

    Hintergrund

    Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.
Sie sind hier:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!